NL1025527A1 - Triazole compounds that are useful in therapy. - Google Patents

Triazole compounds that are useful in therapy.

Info

Publication number
NL1025527A1
NL1025527A1 NL1025527A NL1025527A NL1025527A1 NL 1025527 A1 NL1025527 A1 NL 1025527A1 NL 1025527 A NL1025527 A NL 1025527A NL 1025527 A NL1025527 A NL 1025527A NL 1025527 A1 NL1025527 A1 NL 1025527A1
Authority
NL
Netherlands
Prior art keywords
therapy
useful
triazole compounds
triazole
compounds
Prior art date
Application number
NL1025527A
Other languages
Dutch (nl)
Other versions
NL1025527C2 (en
Inventor
Justin Stephen Bryans
Patrick Stephen
Thomas Ryckmans
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL1025527A1 publication Critical patent/NL1025527A1/en
Application granted granted Critical
Publication of NL1025527C2 publication Critical patent/NL1025527C2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL1025527A 2003-02-19 2004-02-19 Triazole compounds that are useful in therapy. NL1025527C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0303852.8A GB0303852D0 (en) 2003-02-19 2003-02-19 Triazole compounds useful in therapy
GB0303852 2003-02-19

Publications (2)

Publication Number Publication Date
NL1025527A1 true NL1025527A1 (en) 2004-08-23
NL1025527C2 NL1025527C2 (en) 2005-03-14

Family

ID=9953327

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1025527A NL1025527C2 (en) 2003-02-19 2004-02-19 Triazole compounds that are useful in therapy.

Country Status (11)

Country Link
CN (1) CN1751047A (en)
AR (1) AR043210A1 (en)
CL (1) CL2004000293A1 (en)
GB (1) GB0303852D0 (en)
GT (1) GT200400020A (en)
NL (1) NL1025527C2 (en)
PA (1) PA8596101A1 (en)
PE (1) PE20050222A1 (en)
TW (1) TW200500367A (en)
UY (1) UY28201A1 (en)
WO (1) WO2004074291A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325021D0 (en) * 2003-10-27 2003-12-03 Pfizer Ltd Therapeutic combinations
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102004001871A1 (en) * 2004-01-14 2005-09-01 Bayer Healthcare Ag Tricyclic benzazepine derivatives and their use
MX2007002248A (en) * 2004-08-25 2008-10-02 Pfizer Triazolobenzodiazepines and their use as vasopressin antagonists.
EP1877399A1 (en) * 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
MX2011004575A (en) 2008-11-13 2011-06-01 Hoffmann La Roche Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes.
JP5384659B2 (en) * 2008-11-18 2014-01-08 エフ.ホフマン−ラ ロシュ アーゲー Alkylcyclohexyl ether of dihydrotetraazabenzoazulene
MY150837A (en) 2008-11-28 2014-02-28 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
EP2414361A1 (en) 2009-03-31 2012-02-08 ArQule, Inc. Substituted heterocyclic compounds
JP2013510834A (en) * 2009-11-16 2013-03-28 メリテク [1,5] -diazocine derivatives
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) * 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
US9006450B2 (en) * 2010-07-01 2015-04-14 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
TW201242956A (en) 2010-10-07 2012-11-01 Takeda Pharmaceutical Heterocyclic compounds
RU2011122942A (en) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" NEW KINAZ INHIBITORS
US8828989B2 (en) * 2011-09-26 2014-09-09 Hoffmann-La Roche Inc. Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
BR112014007851A2 (en) 2011-10-05 2017-04-18 Hoffmann La Roche cyclohexyl-4h, 6h-oxa-2,3,10b-triaza-benzo [e] azulenes as v1a antagonists
HUE030526T2 (en) 2012-06-13 2017-05-29 Hoffmann La Roche New diazaspirocycloalkane and azaspirocycloalkane
CN102766674A (en) * 2012-07-25 2012-11-07 辉源生物科技(上海)有限公司 Establishment of screening platform for cynomolgus monkey antidiuretic hormone receptor V1A antagonist
SG11201500572YA (en) 2012-09-25 2015-02-27 Hoffmann La Roche New bicyclic derivatives
AR095079A1 (en) 2013-03-12 2015-09-16 Hoffmann La Roche DERIVATIVES OF OCTAHIDRO-PIRROLO [3,4-C] -PIRROL AND PIRIDINA-FENILO
EA201690179A1 (en) 2013-08-19 2016-06-30 Ф. Хоффманн-Ля Рош Аг V1A RECEPTOR ANTAGONISTS FOR TREATMENT OF DISORDERS ASSOCIATED WITH SHEEP PHASE SHIFT
EA201691044A1 (en) 2013-11-26 2016-09-30 Ф. Хоффманн-Ля Рош Аг NEW OCTAGIDRO-CYCLOBUT [1,2-C; 3,4-C '] DIPIRROL-2-IL
PL3077396T3 (en) 2013-12-05 2021-10-04 F. Hoffmann-La Roche Ag Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof
UA119347C2 (en) 2014-03-26 2019-06-10 Ф. Хоффманн-Ля Рош Аг Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
LT3122750T (en) 2014-03-26 2019-11-11 Hoffmann La Roche Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
MA41898A (en) 2015-04-10 2018-02-13 Hoffmann La Roche BICYCLIC QUINAZOLINONE DERIVATIVES
CN108026077B (en) 2015-09-04 2021-11-05 豪夫迈·罗氏有限公司 Phenoxymethyl derivatives
CR20180143A (en) 2015-09-24 2018-05-03 Hoffmann La Roche NEW BICYCLE COMPOUNDS AS DUAL INHIBITORS OF ATX / CA
KR20180054635A (en) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 As an autotaxin (ATX) inhibitor,
RU2724899C2 (en) 2015-09-24 2020-06-26 Ф. Хоффманн-Ля Рош Аг New bicyclic compounds as dual inhibitors of atx/ca
MA42918A (en) 2015-09-24 2018-08-01 Hoffmann La Roche BICYCLIC COMPOUNDS USED AS ATX INHIBITORS
KR20190129924A (en) 2017-03-16 2019-11-20 에프. 호프만-라 로슈 아게 Heterocyclic Compounds Useful as Dual Autotaxin (ATX) / Carbon Anhydrase (CA) Inhibitors
EP3596060B1 (en) 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG New bicyclic compounds as atx inhibitors
US11186577B2 (en) * 2017-06-05 2021-11-30 Blackthorn Therapeutics, Inc. Vasopressin receptor antagonists and products and methods related thereto
TW201938171A (en) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 Tricyclic compounds as vasopressin V1a receptor antagonists
HU231206B1 (en) * 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepines
CN111170983B (en) * 2019-12-26 2021-07-09 中国农业大学 Benzylthio acetamide compound and preparation method and application thereof
TWI804119B (en) * 2020-12-21 2023-06-01 大陸商上海濟煜醫藥科技有限公司 Derivative of triazole fused three rings, manufacturing method and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823475D0 (en) * 1988-10-06 1988-11-16 Merck Sharp & Dohme Chemical compounds
US5438035A (en) * 1994-06-24 1995-08-01 American Cyanamid Company Methods for controlling undesirable plant species with benzodiazepine compounds
US5753648A (en) * 1995-01-17 1998-05-19 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
EP1021444B1 (en) * 1996-11-01 2003-09-24 Wyeth 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
AU772397B2 (en) * 1999-01-19 2004-04-29 Ortho-Mcneil Pharmaceutical, Inc. Tricyclic benzodiazepines as vasopressin receptor antagonists
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists

Also Published As

Publication number Publication date
PE20050222A1 (en) 2005-04-13
AR043210A1 (en) 2005-07-20
GT200400020A (en) 2004-09-21
PA8596101A1 (en) 2005-08-04
WO2004074291A1 (en) 2004-09-02
CL2004000293A1 (en) 2005-01-07
NL1025527C2 (en) 2005-03-14
CN1751047A (en) 2006-03-22
UY28201A1 (en) 2004-09-30
GB0303852D0 (en) 2003-03-26
TW200500367A (en) 2005-01-01

Similar Documents

Publication Publication Date Title
NL1025527A1 (en) Triazole compounds that are useful in therapy.
NL1027833A1 (en) Compounds useful in therapy.
NL1031626A1 (en) Compounds useful in therapy.
ATE522138T1 (en) FUNGICIDAL MIXTURES
SE0302991L (en) Particleboard
NO20054053D0 (en) Triazole compounds useful in therapy.
EG24190A (en) Fungicidal mixtures
DE50304722D1 (en) Fungicidal drug combinations
NO20053189D0 (en) HVC-combination therapy.
AP2005003236A0 (en) Dithianon-based fungicidal mixtures.
AP2005003202A0 (en) Dithianon-based fungicidal mixtures.
ATE353559T1 (en) FUNGICIDAL MIXTURES
IL174791A0 (en) Fungicidal mixtures
IL174129A0 (en) Fungicidal mixtures
ATE390843T1 (en) FUNGICIDAL MIXTURES
IL174790A0 (en) Fungicidal mixtures
IL174158A0 (en) Fungicidal mixtures
ITBG20020034A1 (en) IMPROVED SHOE STRUCTURE.
NO20042850L (en) Cancer treatment
FR2840189B1 (en) HYDRAULIC RETRACTOR
ITRM20020328A1 (en) DIES FOR DNASER.
ITPD20020161A1 (en) DEGERMINATOR MACHINE, IN PARTICULAR FOR THE DEGERMINATION OF CEREALS.
GB0301697D0 (en) Horse shoe
ES1054469Y (en) ANTISEPTIC SET
ITMO20020183A0 (en) PREPARATION FOR DERMOSTIMULATION TREATMENTS

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20041111

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100901